|
|
|
Corporate Profile: Icagen
| Summary: |
Icagen is focused on the discovery, development and commercialization of small molecule drugs that target ion channels.
|
| Address: |
4222 Emperor Boulevard
Suite 350
Durham, NC 27703 |
| Phone
#'s: |
| Main |
(919) 941-5206 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(919) 941-0813 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ICGN |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
